5-year survival and toxicity results of SIB radiotherapy in (very) high-risk prostate cancer

被引：0
|
作者：
Masson, I. [1 ]
Guerin-Charbonnel, C. [2 ]
Azria, D. [3 ]
Pommier, P. [4 ]
Mesgouez-Nebout, N. [5 ]
Giraud, P. [6 ]
Peiffert, D. [7 ]
Chauvet, B. [8 ]
Dudouet, P. [9 ]
Salem, N. [10 ]
Noel, G. [11 ]
Khalifa, J. [12 ]
Latorzeff, I. [13 ]
Mahe, M. A. [14 ]
Supiot, S. [15 ]
机构：
[1] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
[2] Inst Cancerol Ouest Rene Gauducheau, Clin Trial Sponsor Unit Biometry, Nantes, France
[3] Inst Reg Canc Montpellier ICM, Federat Univ Oncol Radiotherapie FOROM, Montpellier, France
[4] Leon Berard Ctr, Radiotherapy, Lyon, France
[5] Inst Cancerol Ouest Paul Papin, Radiotherapy, Angers, France
[6] Georges Pompidou European Hosp, Radiotherapy, Paris, France
[7] Lorraine Canc Inst, Radiotherapy, Vandoeuvre Les Nancy, France
[8] Sainte Catherine Inst, Radiotherapy, Avignon, France
[9] Pont Chaume Clin, Radiotherapy, Montauban, Tarn & Garonne, France
[10] Paoli Calmettes Inst, Radiotherapy, Marseille, France
[11] Cancerol Inst Strasbourg Europe, Radiotherapy, Strasbourg, France
[12] Inst Univ Canc Toulouse Oncopole IUCT Oncopole, Radiotherapy, Toulouse, France
[13] Pasteur Clin, Radiotherapy, Toulouse, France
[14] Francois Baclesse Canc Ctr, Radiotherapy, Caen, France
[15] Inst Cancerol Ouest Rene Gauducheau, Radiotherapy, Nantes, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1465
引用
收藏
页码：S1186 / S1187
页数：2
相关论文
共 50 条
  • [1] Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer
    Masson, Ingrid
    Larriviere, Laurene
    Mahe, Marc-Andre
    Azria, David
    Pommier, Pascal
    Mesgouez-Nebout, Nathalie
    Giraud, Philippe
    Peiffert, Didier
    Chauvet, Bruno
    Dudouet, Philippe
    Salem, Naji
    Noel, Georges
    Khalifa, Jonathan
    Latorzeff, Igor
    Guerin-Charbonnel, Catherine
    Supiot, Stephane
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 44
  • [2] VMAT SBRT for localized prostate cancer: 5-year update on toxicity and survival
    D'Agostino, G. R.
    Di Brina, L.
    Franzese, C.
    Iftode, C.
    Mancosu, P.
    De Rose, F.
    Clerici, E.
    Reggiori, G.
    Badalamenti, M.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S625 - S626
  • [3] Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
    Kristiina Vuolukka
    Päivi Auvinen
    Erno Tiainen
    Jan-Erik Palmgren
    Janne Heikkilä
    Jan Seppälä
    Sirpa Aaltomaa
    Vesa Kataja
    Radiation Oncology, 15
  • [4] Radiotherapy for high-risk prostate cancer
    Jahan J. Mohiuddin
    Brock R. Baker
    Ronald C. Chen
    Nature Reviews Urology, 2015, 12 : 145 - 154
  • [5] Radiotherapy for high-risk prostate cancer
    Mohiuddin, Jahan J.
    Baker, Brock R.
    Chen, Ronald C.
    NATURE REVIEWS UROLOGY, 2015, 12 (03) : 145 - 154
  • [6] CANCER OF THE LARYNX - 5-YEAR RESULTS OF RADIOTHERAPY
    CUTLER, M
    RADIOLOGY, 1948, 51 (04) : 509 - 520
  • [7] Acute toxicity results using dynamic intensity modulated radiotherapy (dIMRT) in high-risk prostate cancer
    Pervez, N.
    Pearcey, R.
    Parliament, M.
    Yee, D.
    Amanie, J.
    Murtha, A.
    Wachowicz, K.
    Field, C.
    Mackenzie, M.
    Fallone, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S365 - S365
  • [8] Stereotactic body radiotherapy for high-risk prostate cancer (5 treatment days): Toxicity results of a phase II trial.
    Kishan, Amar Upadhyaya
    Fuller, Donald B.
    Steinberg, Michael L.
    Ramirez, Victoria
    Agazaryan, Nzhde
    Ruan, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [9] Concomitant Hypofractionated IMRT Boost for High-Risk Prostate Cancer: 5 Year Results
    Cheung, P.
    Loblaw, D.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Zhang, L.
    Mamedov, A.
    Deabreu, A.
    Morton, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S106 - S106
  • [10] Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: Preliminary Toxicity Results of a Phase 2 Trial
    Kishan, A. U.
    Fuller, D. B.
    Steinberg, M. L.
    Ramirez, V.
    Ostendorf, E.
    Tsai, S. H.
    Agazaryan, N.
    Ruan, D.
    Cao, M.
    Kupelian, P. A.
    King, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E248 - E248
12345